rxstat › Drug prices › Abacavir / Dolutegravir / Lamivudine

Abacavir / Dolutegravir / Lamivudine (Triumeq) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Abacavir / Dolutegravir / Lamivudine 600 mg / 50 mg / 300 mg tablet costs about $48.36 to $53.14 per tablet on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Abacavir / Dolutegravir / Lamivudine has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNBNS
600 mg / 50 mg / 300 mg Tabletper tablet$53.14not covered$52.43$53.14$48.36–
Plan coverageNot coveredSpecial approvalCoveredCoveredNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Triumeq 600 mg / 50 mg / 300 mg Tablet · VIV
    DIN 02430932 · $53.14/tablet · Not covered
Saskatchewan: 1 product
  • Triumeq 600 mg / 50 mg / 300 mg Tablet · VII
    DIN 02430932 · $52.43/tablet · Special approval
Ontario: 1 product
  • Triumeq 600 mg / 50 mg / 300 mg Tablet · ViiV Healthcare ULC
    DIN 02430932 · $53.14/tablet · Covered
New Brunswick: 1 product
  • Triumeq 600 mg / 50 mg / 300 mg Tablet · VIV
    DIN 02430932 · $48.36/tablet · Covered
Nova Scotia: 1 product
  • Triumeq 600 mg / 50 mg / 300 mg Tablet · VIV
    DIN 02430932 · no listed price · Not covered

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Abacavir / Dolutegravir / Lamivudine. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Abacavir / Dolutegravir / Lamivudine cost in Canada?

Abacavir / Dolutegravir / Lamivudine 600 mg / 50 mg / 300 mg tablet costs about $48.36 to $53.14 per tablet on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Is Abacavir / Dolutegravir / Lamivudine covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: covered; Nova Scotia: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (direct acting antivirals)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.